Search Results - cetuximab antibody

Rovalpituzumab Biosimilar, N297A Mutant C108P.NA Syd Labs

Rovalpituzumab Biosimilar, N297A Mutant | C108P.NA

Rovalpituzumab Biosimilar, N297A Mutant. The research grade rovalpituzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally...

C052P.NA Polatuzumab Biosimilar, N297A Mutant C052P.NA Syd Labs

Polatuzumab Biosimilar, N297A Mutant | C052P.NA

Polatuzumab Biosimilar, N297A Mutant. The research grade polatuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally...

Gemtuzumab Biosimilar, Endotoxin 0.05 EUmg C049P.05 Syd Labs

Gemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C049P.05

Gemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Gemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Omalizumab Biosimilar C020P.NA Syd Labs

Omalizumab Biosimilar, N297A Mutant | C020P.NA

Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...

Palivizumab Biosimilar C021P.NA Syd Labs

Palivizumab Biosimilar, N297A Mutant | C021P.NA

Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...